» Articles » PMID: 21068419

Population-attributable Fractions of Axis I and Axis II Mental Disorders for Suicide Attempts: Findings from a Representative Sample of the Adult, Noninstitutionalized US Population

Overview
Specialty Public Health
Date 2010 Nov 12
PMID 21068419
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We aimed to determine the percentage of suicide attempts attributable to individual Axis I and Axis II mental disorders by studying population-attributable fractions (PAFs) in a nationally representative sample.

Methods: Data were from the National Epidemiologic Survey on Alcohol and Related Conditions Wave 2 (NESARC; 2004-2005), a large (N = 34 653) survey of mental illness in the United States. We used multivariate logistic regression to compare individuals with and without a history of suicide attempt across Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Axis I disorders (anxiety, mood, psychotic, alcohol, and drug disorders) and all 10 Axis II personality disorders. PAFs were calculated for each disorder.

Results: Of the 25 disorders we examined in the model, 4 disorders had notably high PAF values: major depressive disorder (PAF = 26.6%; 95% confidence interval [CI] = 20.1, 33.2), borderline personality disorder (PAF = 18.1%; 95% CI = 13.4, 23.5), nicotine dependence (PAF = 8.4%; 95% CI = 3.4, 13.7), and posttraumatic stress disorder (PAF = 6.3%; 95% CI = 3.2, 10.0).

Conclusions: Our results provide new insight into the relationships between mental disorders and suicide attempts in the general population. Although many mental illnesses were associated with an increased likelihood of suicide attempt, elevated rates of suicide attempts were mostly attributed to the presence of 4 disorders.

Citing Articles

Amygdala response predicts clinical symptom reduction in patients with borderline personality disorder: A pilot fMRI study.

Geurts D, van den Heuvel T, Huys Q, Verkes R, Cools R Front Behav Neurosci. 2022; 16:938403.

PMID: 36110290 PMC: 9468714. DOI: 10.3389/fnbeh.2022.938403.


Risk-Taking Behavior among Suicide Attempters.

Abdoli N, Salari N, Farnia V, Khodamoradi M, Jahangiri S, Mohammadi M J Clin Med. 2022; 11(14).

PMID: 35887941 PMC: 9320022. DOI: 10.3390/jcm11144177.


Correlates of Presence and Remission of Post-trauma Stress Disorder in Incarcerated Women: A Case-Control Study Design.

Zhong S, Zhu X, Mellsop G, Zhou J, Wang X Front Psychiatry. 2021; 12:748518.

PMID: 34955914 PMC: 8692654. DOI: 10.3389/fpsyt.2021.748518.


Adolescent suicide attempts in three diverse island nations: patterns, contextual differences and demographic associations.

Fu J, Abiodun O, Wilson M, Shaikh M BMC Res Notes. 2021; 14(1):464.

PMID: 34949211 PMC: 8697498. DOI: 10.1186/s13104-021-05804-4.


Risk Assessment on Suicide Death and Attempt among Chinese Rural Youths Aged 15-34 Years.

Sun L, Zhang J, Lamis D, Wang Y Int J Environ Res Public Health. 2021; 18(24).

PMID: 34948972 PMC: 8708552. DOI: 10.3390/ijerph182413362.


References
1.
Kessler R, Borges G, Sampson N, Miller M, Nock M . The association between smoking and subsequent suicide-related outcomes in the National Comorbidity Survey panel sample. Mol Psychiatry. 2008; 14(12):1132-42. PMC: 2784156. DOI: 10.1038/mp.2008.78. View

2.
Rockhill B, Newman B, WEINBERG C . Use and misuse of population attributable fractions. Am J Public Health. 1998; 88(1):15-9. PMC: 1508384. DOI: 10.2105/ajph.88.1.15. View

3.
Kessler R, Chiu W, Demler O, Merikangas K, Walters E . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):617-27. PMC: 2847357. DOI: 10.1001/archpsyc.62.6.617. View

4.
Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

5.
Grant B, Harford T, Muthen B, Yi H, Hasin D, Stinson F . DSM-IV alcohol dependence and abuse: further evidence of validity in the general population. Drug Alcohol Depend. 2006; 86(2-3):154-66. DOI: 10.1016/j.drugalcdep.2006.05.019. View